{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:20:06Z","timestamp":1776475206022,"version":"3.51.2"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["G078332"],"award-info":[{"award-number":["G078332"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0900950"],"award-info":[{"award-number":["G0900950"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffman-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1006299","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T14:15:30Z","timestamp":1492092930000},"page":"e1006299","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection"],"prefix":"10.1371","volume":"13","author":[{"given":"Jessica","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-9756","authenticated-orcid":true,"given":"Vincent C.","family":"Emery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepali","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Asberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan G.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo A.","family":"Bignamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Humar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2149-5917","authenticated-orcid":true,"given":"Avidan U.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"issue":"22","key":"ref1","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1128\/JVI.74.22.10401-10406.2000","article-title":"Toward a comprehensive phylogeny for mammalian and avian herpesviruses","volume":"74","author":"DJ McGeoch","year":"2000","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/978-1-4614-1680-7_15","article-title":"Viral immunomodulatory proteins: usurping host genes as a survival strategy","volume":"738","author":"P Engel","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref3","first-page":"161","article-title":"Chapter 8 Cytomegalovirus in Principles and Practices of Clinical Virology","author":"PD Griffiths","year":"2009"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation\u2014challenging the status quo","volume":"21","author":"JA Fishman","year":"2007","journal-title":"Clin Transplant"},{"issue":"Suppl 2","key":"ref5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1034\/j.1399-3062.2001.00003.x","article-title":"Economic impact of cytomegalovirus in solid organ transplantation","volume":"3","author":"CV Paya","year":"2001","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"RF Pass","year":"2009","journal-title":"N Engl J Med"},{"issue":"9773","key":"ref7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"PD Griffiths","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1473-3099(11)70344-9","article-title":"A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"12","author":"MA Kharfan-Dabaja","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"2\u20133","key":"ref9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"KK Biron","year":"2006","journal-title":"Antiviral Res"},{"issue":"2","key":"ref10","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","author":"EM Hodson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hon.856","article-title":"Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation","volume":"26","author":"F Baldanti","year":"2008","journal-title":"Hematol Oncol"},{"issue":"6382","key":"ref12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir","volume":"358","author":"E Littler","year":"1992","journal-title":"Nature"},{"issue":"6382","key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"V Sullivan","year":"1992","journal-title":"Nature"},{"issue":"1A","key":"ref14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9343(82)90055-9","article-title":"Mechanism of action and selectivity of acyclovir","volume":"73","author":"GB Elion","year":"1982","journal-title":"Am J Med"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/0006-2952(93)90611-Y","article-title":"Varicella-zoster virus thymidine kinase. Characterization and substrate specificity","volume":"46","author":"GB Roberts","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"ref16","article-title":"Virus Dynamics","author":"M.A Nowak","year":"2000"},{"issue":"5255","key":"ref17","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"issue":"13","key":"ref18","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1073\/pnas.94.13.6971","article-title":"Virus dynamics and drug therapy","volume":"94","author":"S Bonhoeffer","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/hep.24272","article-title":"Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration","volume":"53","author":"J Guedj","year":"2011","journal-title":"Hepatology"},{"issue":"5386","key":"ref20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"AU Neumann","year":"1998","journal-title":"Science"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.gastro.2005.01.049","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"128","author":"H Dahari","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2005.05.016","article-title":"International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C","volume":"43","author":"S Zeuzem","year":"2005","journal-title":"J Hepatol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1073\/pnas.93.9.4398","article-title":"Viral dynamics in hepatitis B virus infection","volume":"93","author":"MA Nowak","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1084\/jem.193.7.847","article-title":"Kinetics of acute hepatitis B virus infection in humans","volume":"193","author":"SA Whalley","year":"2001","journal-title":"J Exp Med"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1084\/jem.190.2.177","article-title":"The dynamics of human cytomegalovirus replication in vivo","volume":"190","author":"VC Emery","year":"1999","journal-title":"J Exp Med"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.140123497","article-title":"Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy","volume":"97","author":"VC Emery","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2011.03.184","article-title":"Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation","volume":"90","author":"DG Wolf","year":"2011","journal-title":"Antiviral Res"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1086\/340653","article-title":"Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts","volume":"185","author":"VC Emery","year":"2002","journal-title":"J Infect Dis"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"A Asberg","year":"2007","journal-title":"Am J Transplant"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-10-2","article-title":"Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+\/R- transplant recipients","volume":"10","author":"N Perrottet","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2893.2002.00377.x","article-title":"First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral decline","volume":"9","author":"JE Layden","year":"2002","journal-title":"J Viral Hepat"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcv.2012.01.015","article-title":"Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy","volume":"54","author":"VC Emery","year":"2012","journal-title":"J Clin Virol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"D Kumar","year":"2009","journal-title":"Am J Transplant"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"SF Atabani","year":"2012","journal-title":"Am J Transplant"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/AAC.48.12.4745-4753.2004","article-title":"Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections","volume":"48","author":"ER Kern","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"ref36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"FM Marty","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study","volume":"27","author":"S Stoelben","year":"2014","journal-title":"Transpl Int"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1111\/j.1600-6143.2012.04231.x","article-title":"Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial","volume":"12","author":"DJ Winston","year":"2012","journal-title":"Am J Transplant"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood.V97.4.867","article-title":"Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes","volume":"97","author":"WG Nichols","year":"2001","journal-title":"Blood"},{"issue":"4","key":"ref40","first-page":"526","article-title":"Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients","volume":"90","author":"G Gerna","year":"2005","journal-title":"Haematologica"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2010.06.018","article-title":"Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy","volume":"49","author":"HC Buyck","year":"2010","journal-title":"J Clin Virol"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/jir457","article-title":"Mixed infection and strain diversity in congenital cytomegalovirus infection","volume":"204","author":"SA Ross","year":"2011","journal-title":"J Infect Dis"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/INF.0b013e31829bb0b9","article-title":"Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection","volume":"32","author":"SK Pati","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1086\/382753","article-title":"Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients","volume":"189","author":"G Boivin","year":"2004","journal-title":"J Infect Dis"},{"issue":"12","key":"ref45","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1128\/JCM.01341-08","article-title":"Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay","volume":"46","author":"X Pang","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"7\u20138","key":"ref46","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.mcm.2008.06.003","article-title":"A Model for HCMV Infection in Immunosuppressed Patients","volume":"49","author":"GM Kepler","year":"2009","journal-title":"Math Comput Model"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1006386","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T00:00:00Z","timestamp":1494374400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1006299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T11:54:26Z","timestamp":1540036466000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1006299"}},"subtitle":[],"editor":[{"given":"Donald M.","family":"Coen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1006299","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.ppat.1006386","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]}}}